IN2014DN05972A - - Google Patents

Info

Publication number
IN2014DN05972A
IN2014DN05972A IN5972DEN2014A IN2014DN05972A IN 2014DN05972 A IN2014DN05972 A IN 2014DN05972A IN 5972DEN2014 A IN5972DEN2014 A IN 5972DEN2014A IN 2014DN05972 A IN2014DN05972 A IN 2014DN05972A
Authority
IN
India
Prior art keywords
diseases associated
present
glucose metabolism
therapeutic agent
abnormal glucose
Prior art date
Application number
Other languages
English (en)
Inventor
Ichiro Hisatome
Shunsuke Tsujimoto
Takashi Shirakura
Shinya Hiramitsu
Original Assignee
Teijin Pharma Ltd
Nat Univ Corp Tottori Univ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teijin Pharma Ltd, Nat Univ Corp Tottori Univ filed Critical Teijin Pharma Ltd
Publication of IN2014DN05972A publication Critical patent/IN2014DN05972A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
IN5972DEN2014 2012-01-27 2013-01-25 IN2014DN05972A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2012015351 2012-01-27
PCT/JP2013/051627 WO2013111870A1 (fr) 2012-01-27 2013-01-25 Agent thérapeutique pour le diabète

Publications (1)

Publication Number Publication Date
IN2014DN05972A true IN2014DN05972A (fr) 2015-06-26

Family

ID=48873581

Family Applications (1)

Application Number Title Priority Date Filing Date
IN5972DEN2014 IN2014DN05972A (fr) 2012-01-27 2013-01-25

Country Status (15)

Country Link
US (1) US20150005506A1 (fr)
EP (1) EP2808018B1 (fr)
JP (1) JP5924699B2 (fr)
KR (1) KR20140134266A (fr)
CN (1) CN104066430A (fr)
AR (1) AR089812A1 (fr)
AU (1) AU2013212865A1 (fr)
BR (1) BR112014017902A2 (fr)
CA (1) CA2862602A1 (fr)
HK (1) HK1201209A1 (fr)
IN (1) IN2014DN05972A (fr)
MX (1) MX2014008484A (fr)
RU (1) RU2014134845A (fr)
TW (1) TW201334779A (fr)
WO (1) WO2013111870A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104610188B (zh) * 2015-02-10 2016-07-27 佛山市赛维斯医药科技有限公司 含苯基脒结构的腈基苯噻唑羧酸酰胺类化合物、其制备及用途
CN104628672A (zh) * 2015-02-10 2015-05-20 佛山市赛维斯医药科技有限公司 一类含苯基脒结构的烷氧苯基噻唑羧酸酰胺类化合物及用途
CN104628673A (zh) * 2015-02-10 2015-05-20 佛山市赛维斯医药科技有限公司 一类含叔丁基脒结构的腈基苯噻唑羧酸酰胺类化合物及用途
CN104610190B (zh) * 2015-02-10 2016-08-17 佛山市赛维斯医药科技有限公司 一类含环丙基脒结构的卤代苯基噻唑羧酸酰胺类化合物及用途
CN104628671B (zh) * 2015-02-10 2016-04-13 佛山市赛维斯医药科技有限公司 含苯基脒结构的硝基苯噻唑羧酸酰胺类化合物及用途
KR102473677B1 (ko) * 2015-08-17 2022-12-02 삼성디스플레이 주식회사 액정 표시 장치
JP6732004B2 (ja) 2016-02-19 2020-07-29 国立大学法人鳥取大学 認知症治療薬または予防薬

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE122008000051I1 (de) 1990-11-30 2009-02-05 Teijin Ltd 2-arylthiazolderivat sowie dieses enthaltendes arzneimittel
HUP9902721A2 (hu) * 1997-11-25 1999-12-28 The Procter & Gamble Co. Tömény textillágyító készítmény és ehhez alkalmazható magas telítetlenségű textillágyító vegyület
US20050074442A1 (en) * 2002-03-13 2005-04-07 Natarajan Ranganathan Compositions and methods for augmenting kidney function
EP1778261A4 (fr) * 2004-07-21 2010-08-11 Univ Florida Compositions et procedes de traitement et de prevention de la resistance a l'insuline
AU2006276933A1 (en) * 2005-07-21 2007-02-15 University Of Florida Research Foundation, Inc. Compositions and methods for treatment and prevention of hyperuricemia related health consequences
WO2007019153A2 (fr) 2005-08-03 2007-02-15 Tap Pharmaceutical Products, Inc. Methodes de traitement de l'hypertension
CA2630639A1 (fr) * 2005-11-21 2007-05-31 Tap Pharmaceutical Products, Inc. Traitement d'allongement de l'intervalle qt et maladies associees
JP2007210978A (ja) * 2006-02-13 2007-08-23 Hiroshima Univ 耐糖能障害、ｉｉ型糖尿病、高脂血症、メタボリックシンドローム、内臓脂肪型肥満、脂肪肝または非アルコール性脂肪性肝炎の予防・治療剤
EP2101761A4 (fr) 2006-11-13 2010-01-27 Takeda Pharmaceuticals North A Procédés pour préserver la fonction rénale au moyen d'inhibiteurs de xanthine oxydoréductase
EP2842948A1 (fr) * 2007-11-27 2015-03-04 Ardea Biosciences, Inc. Nouveaux composés, compositions et procédés d'utilisation
TWI613203B (zh) * 2008-03-31 2018-02-01 Ｃ＆Ｃ新藥研究所 雜環衍生物
KR101613611B1 (ko) * 2008-04-30 2016-04-19 웰스태트 테러퓨틱스 코포레이션 요산 감소용 테트라졸 화합물
JP5820269B2 (ja) * 2008-05-22 2015-11-24 アストラゼネカ・アクチエボラーグＡｓｔｒａｚｅｎｅｃａ Ａｋｔｉｅｂｏｌａｇ Ｓｇｌｔ２阻害剤を使用する高尿酸血症の治療方法およびｓｇｌｔ２阻害剤を含有する組成物
CN102256488A (zh) * 2008-10-19 2011-11-23 理查德·J·约翰逊 伴随代谢失衡慢性肾病的治疗组合物和治疗方法
EP2470268A4 (fr) * 2009-08-24 2012-12-26 Wound Man Pty Ltd Diagnostic et thérapie des plaies ciblant les purines
PE20130574A1 (es) * 2010-06-16 2013-06-01 Takeda Pharmaceuticals Usa Inc Nuevas formas de dosificacion de liberacion modificada de un inhibidor de la xantina oxidorreductasa o de inhibidores de xantina oxidasa
CN102958521A (zh) * 2010-06-25 2013-03-06 帝人制药株式会社 缓释性高血压和肾功能不全治疗剂

Also Published As

Publication number Publication date
CA2862602A1 (fr) 2013-08-01
EP2808018A1 (fr) 2014-12-03
RU2014134845A (ru) 2016-03-20
EP2808018A4 (fr) 2015-07-15
EP2808018B1 (fr) 2018-03-14
AR089812A1 (es) 2014-09-17
US20150005506A1 (en) 2015-01-01
WO2013111870A1 (fr) 2013-08-01
JPWO2013111870A1 (ja) 2015-05-11
CN104066430A (zh) 2014-09-24
TW201334779A (zh) 2013-09-01
MX2014008484A (es) 2014-10-14
HK1201209A1 (en) 2015-08-28
JP5924699B2 (ja) 2016-05-25
KR20140134266A (ko) 2014-11-21
BR112014017902A2 (pt) 2017-08-22
AU2013212865A1 (en) 2014-08-14

Similar Documents

Publication Publication Date Title
PH12017501429A1 (en) Derivatives of betulin
PH12015502839A1 (en) Antiviral compounds
MX2016006336A (es) Compuestos pirazolopirimidina.
GEP20207105B (en) 1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2yl carbamate derivatives as magl inhibitors
IN2015MN00404A (fr)
AU2012214029A8 (en) Rorgammat inhibitors
MX2015003594A (es) Agente terapeutico o profilactico para sindrome de lisis tumoral.
MX363127B (es) Derivados de benzotiofeno como inhibidores del receptor de estrogeno.
IN2014DN05972A (fr)
MX361653B (es) Procedimiento para la preparación de derivados del ácido biliar.
MY183312A (en) Pharmaceutical formulation
MX2015010971A (es) Derivado novedoso de pirazol.
JO3530B1 (ar) مركبات بيريدازين 1،4-ثنائية الإرتباط ونظائرها وطرق معالجة نقص smn وحالاته المرضية.
IN2014MN02106A (fr)
IN2015DN00185A (fr)
AU2012321815A8 (en) 1 - arylcarbonyl - 4 - oxy - piperidine compounds useful for the treatment of neurodegenerative diseases
MY187718A (en) Pharmaceutical formulations
PH12015501752B1 (en) Substituted bisphenyl butanoic phosphonic acid derivatives as nep inhibitors
MX364400B (es) Compuestos de tetraciclina.
WO2011123536A8 (fr) Composés polycycliques de tétracycline
MX2021010046A (es) Nueva composicion terapeutica que contiene ingrediente activo de apomorfinas.
NZ711343A (en) Sodium salt of (2s, 5r)-6-benzyloxy-7-oxo-1,6-diaza-bicyclo [3.2.1 ] octane-2-carboxylic acid and its preparation
IN2014CN04449A (fr)
MY173491A (en) Therapeutic or prophylactic agent for biliary tract diseases
MX2015011375A (es) Moduladores del receptor acoplado a proteina-g 120 (gpr120) de acido biciclo-[2.2.1].